TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial.

Filippo Pietrantonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.